Skip to content
Canada
-
Sanofi invests US$212M in Toronto’s AI hub to accelerate drug innovation
The project is backed by a conditional grant of up to C$5 million (US$3.6 million) from the Ontario government through the Invest Ontario Fund.
-
-
GSK renews USD250M manufacturing deal with Bora Pharmaceuticals through 2030
Under the renewed agreement, Bora will provide end-to-end manufacturing services for more than 20 commercial GSK product lines.
-
Celltrion’s Eydenzelt gets Health Canada approval for ophthalmology market
Eydenzelt will be available in both pre-filled syringe and vial formats, and it is approved for all the same uses as the original Eylea treatment.